Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Give their written informed consent.
2. Abide by at least one of the following conditions:
* Obtain no partial response after first-line chemotherapy including anthracyclines + rituximab (R-CHOP, R-MegaCHOP, R-EPOCH or the like), or else
* Absence of partial response after having received salvage (post-induction) chemotherapy including R-IFE, R-ESHAP, R-ICE or the like.
* Patients on first recidivation who do not attain partial remission after salvage chemotherapy.
* Patients with transformed lymphoma, on first partial remission (No CR).
3. Stable disease at the time of transplantation.
4. Age ≥ 18 but ≤ 70.
5. Life expectancy of greater than three months.
Additionally, to be able to undergo haematopoietic stem cell transplantation, all patients should satisfy the requirements of routine clinical practice, i.e.:
1. Performance status (ECOG) \< 3.
2. FEV1, DLCO and FVC ≥ 50% of the normal theoretical values.
